MAIA Biotechnology, Inc. MAIA
- ateganosine — Non-Small Cell Lung Cancer Phase 2
- ateganosine — Hepatocellular Carcinoma Phase 2
- ateganosine — Colorectal Cancer Phase 2
- ateganosine — Pediatric-Type Diffuse High-Grade Glioma Preclinical
- MAIA-2021-20 Preclinical
- MAIA-2022-12 Preclinical
- MAIA-2021-029 Preclinical